Acute Myeloid Leukemia Survival Rates

Acute Myeloid Leukemia Survival Rates

Acute Myeloid Leukemia Survival Rates

Glioblastoma Multiforme, or commonly called Glioblastoma, is a deadly type of a brain tumor. Of the 17,000 new brain tumor cases diagnosed in the USA each year, more than 50% of them are of the Glioblastoma type. The disease is characterized by atypical symptoms such as memory deficit, headache and vomiting. For an unknown reason, Glioblastoma affects males more than females.

Glioblastoma Tumors Are The Most Aggressive Brain Tumors

The survival rate of Glioblastoma patients is very low. Without treatment, the average survival time of patients is as low as 3 months and even treated patients often survive for only a few months. The tumors often become resistant to chemotherapy treatment which complicates treatment as normal brain tissues becomes easily damaged from increased doses of radiotherapy or chemotherapy.

New Therapeutic Approach to Attack Tumor Cells

Using a mouse model of Glioblastoma Multiform, a team of American researchers, led by Pedro R Lowenstein and Maria G Castro from The University of California and Cedars Sinai Medical Center, have developed a viral strategy able to stimulate the immune system to attack the brain tumor cells.